Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 17- Open
- $136.81
- 52-wk high
- $155.38
- High
- $138.43
- 52-wk low
- $106.44
- Low
- $135.91
- Prev close
- $138.14
Smart money
Earnings
Reported Aug 3, 2026
Earnings came in 4.5% above what analysts expected.
Financials
Sep 2025 to Jun 2026
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $7.77B | $7.92B | $6.96B | $7.80B |
| Cost of what it soldCost of revenue | $1.57B | $1.62B | $1.45B | $1.58B |
| Gross profit | $6.20B | $6.30B | $5.51B | $6.22B |
| What it spent | ||||
| Research and development | $1.35B | $1.58B | $1.37B | $1.76B |
| Sales and adminSelling, general and administrative | $528.0M | $652.0M | $553.0M | $1.92B |
| Other operating costsOperating costs not itemised in the filing's summary | $999.0M | $1.08B | $1.00B | $12.93B |
| Total operating expenses | $2.87B | $3.31B | $2.93B | $16.62B |
| What was left | ||||
| Operating profitOperating income | $3.33B | $2.99B | $2.69B | -$10.39B |
| Interest on debtInterest expense | $256.0M | $255.0M | $240.0M | $247.0M |
| Profit before tax | $3.64B | $2.08B | $2.58B | -$10.25B |
| TaxIncome tax expense | $589.0M | -$105.0M | $559.0M | $242.0M |
| Net profitNet income | $3.05B | $2.18B | $2.02B | -$10.50B |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $4.58B | $3.02B | $3.51B | -$10.01B |
Technicals
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
$138.3620D support
News
News
What the news says
Coverage is bullish
34 bullish · 13 neutral · 3 bearish
Tone of tracked coverage
In Win for Gilead, Fourth Circuit Affirms Injunction Blocking Drug Importation Scheme
BullishAug 17J&J Secures $2.58B Option to Acquire Sail Biomedicines
Leans bullishAug 17Simplicity Wealth LLC Invests $1.36 Million in Gilead Sciences, Inc. $GILD
Leans bullishAug 17